YING YUAN to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications YING YUAN has written about Randomized Controlled Trials as Topic.
Connection Strength
1.278
-
Utility-based designs for randomized comparative trials with categorical outcomes. Stat Med. 2016 10 30; 35(24):4285-4305.
Score: 0.312
-
Bayesian sequential monitoring design for two-arm randomized clinical trials with noncompliance. Stat Med. 2015 Jun 15; 34(13):2104-15.
Score: 0.287
-
A Bayesian response-adaptive covariate-balanced randomization design with application to a leukemia clinical trial. Stat Med. 2011 May 20; 30(11):1218-29.
Score: 0.218
-
On the usefulness of outcome-adaptive randomization. J Clin Oncol. 2011 May 01; 29(13):e390-2; author reply e393.
Score: 0.218
-
A direct method to evaluate the time-dependent predictive accuracy for biomarkers. Biometrics. 2015 Jun; 71(2):439-49.
Score: 0.072
-
Bayesian adaptive phase II screening design for combination trials. Clin Trials. 2013; 10(3):353-62.
Score: 0.062
-
Bayesian phase II adaptive randomization by jointly modeling time-to-event efficacy and binary toxicity. Lifetime Data Anal. 2011 Jan; 17(1):156-74.
Score: 0.051
-
Novel Clinical Trial Designs with Dose Optimization to Improve Long-term Outcomes. Clin Cancer Res. 2023 11 14; 29(22):4549-4554.
Score: 0.033
-
Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update. Clin Trials. 2019 12; 16(6):645-656.
Score: 0.024